RxDoctor Payments Data

Matthew Kappus, MD

Gastroenterology · Durham, NCNPI 1235365297

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,105 of the $3,255 with a category attached, or 95.4%. Every reported general payment came from a single manufacturer, Mallinckrodt Hospital Products Inc..

$3,255in general payments, 2019–2025

Across 2 payments — averaging $1627.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$3K
$382,115in research payments, 2019–2025

Across 154 payments — averaging $2481.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Pharma SAS$234K
  • GSK$133K
  • Bausch Health US, LLC$15K

What the payments were for

  • Consulting fees$3,10595%
  • Food & beverage$1505%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mallinckrodt Hospital Products Inc.2$3,255

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,255 in reported general payments places this provider in the 60th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Medicare billing

Part B allowed, 2024
$55,774
Medicare patients
249
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin74$250,485
VeltassaPatiromer Calcium Sorbitex46$57,068
VemlidyTenofovir Alafenamide24$33,773
Ursodiol98$13,705
Envarsus XrTacrolimus23$11,645
Mycophenolate Mofetil63$9,212
Tacrolimus69$8,773
EliquisApixaban11$6,579
LinzessLinaclotide12$6,105
Lactulose49$1,779
Mycophenolic AcidMycophenolate Sodium14$1,755
Azathioprine45$1,467
Spironolactone99$1,433
Cyclosporine ModifiedCyclosporine, Modified14$893
Pantoprazole Sodium77$738

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →